Jiali Nie

Wuhan, 430030, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

The clinicopathologic features of fulminant myocarditis.

The clinicopathologic features of fulminant myocarditis.

Journal: Journal of advanced research

Published: April 20, 2025

CD36 attenuates pressure overload-induced myocardial insulin resistance via HSF1-dependent HSP90α suppression and competitive disruption of the HSP90α-InsR complex.

CD36 attenuates pressure overload-induced myocardial insulin resistance via HSF1-dependent HSP90α suppression and competitive disruption of the HSP90α-InsR complex.

Journal: Journal of translational medicine

Published: March 27, 2025

Deep insight into cytokine storm: from pathogenesis to treatment.

Deep insight into cytokine storm: from pathogenesis to treatment.

Journal: Signal transduction and targeted therapy

Published: August 09, 2024

Obesity and atrial fibrillation: a narrative review from arrhythmogenic mechanisms to clinical significance.

Obesity and atrial fibrillation: a narrative review from arrhythmogenic mechanisms to clinical significance.

Journal: Cardiovascular diabetology

Published: January 05, 2023

Homology-directed repair of an MYBPC3 gene mutation in a rat model of hypertrophic cardiomyopathy.

Homology-directed repair of an MYBPC3 gene mutation in a rat model of hypertrophic cardiomyopathy.

Journal: Gene therapy

Published: October 24, 2022

Mechanism of histone deacetylases in cardiac hypertrophy and its therapeutic inhibitors.

Mechanism of histone deacetylases in cardiac hypertrophy and its therapeutic inhibitors.

Journal: Frontiers in cardiovascular medicine

Published: April 29, 2022

Epigenetic Mechanism and Therapeutic Implications of Atrial Fibrillation.

Epigenetic Mechanism and Therapeutic Implications of Atrial Fibrillation.

Journal: Frontiers in cardiovascular medicine

Published: August 24, 2021

Erratum to: MYH7B variants cause hypertrophic cardiomyopathy by activating the CaMK-signaling pathway.

Erratum to: MYH7B variants cause hypertrophic cardiomyopathy by activating the CaMK-signaling pathway.

Journal: Science China. Life sciences

Published: August 10, 2021

Infection complications in febrile chimeric antigen receptor (CAR)-T recipients during the peri-CAR-T cell treatment period examined using metagenomic next-generation sequencing (mNGS).

Infection complications in febrile chimeric antigen receptor (CAR)-T recipients during the peri-CAR-T cell treatment period examined using metagenomic next-generation sequencing (mNGS).

Journal: Cancer communications (London, England)

Published: July 23, 2021

Trimetazidine Attenuates Heart Failure by Improving Myocardial Metabolism via AMPK.

Trimetazidine Attenuates Heart Failure by Improving Myocardial Metabolism via AMPK.

Journal: Frontiers in pharmacology

Published: May 10, 2021

The role of CD36 in cardiovascular disease.

The role of CD36 in cardiovascular disease.

Journal: Cardiovascular research

Published: May 20, 2020

MYH7B variants cause hypertrophic cardiomyopathy by activating the CaMK-signaling pathway.

MYH7B variants cause hypertrophic cardiomyopathy by activating the CaMK-signaling pathway.

Journal: Science China. Life sciences

Published: September 04, 2019

Showing 1-12 of 17

Last Updated: 09/26/2026